Published in Cancer Detect Prev on September 23, 2005
Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev (2006) 5.08
Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers (Basel) (2011) 2.31
Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer. BMC Med Genomics (2009) 1.91
Systems biology of cisplatin resistance: past, present and future. Cell Death Dis (2014) 1.74
High DNA methyltransferase 3B expression mediates 5-aza-deoxycytidine hypersensitivity in testicular germ cell tumors. Cancer Res (2009) 0.99
Global DNA hypermethylation-associated cancer chemotherapy resistance and its reversion with the demethylating agent hydralazine. J Transl Med (2006) 0.98
Can the state of cancer chemotherapy resistance be reverted by epigenetic therapy? Mol Cancer (2006) 0.83
PARADOXICAL ROLES OF DUAL OXIDASES IN CANCER BIOLOGY. Free Radic Biol Med (2017) 0.83
New approaches to pharmacotherapy of tumors of the nervous system during childhood and adolescence. Pharmacol Ther (2009) 0.78
A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML. Clin Epigenetics (2017) 0.75
Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells. Mol Neurobiol (2016) 0.75
Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1. Cancer Res (2005) 1.50
Caspase inhibition switches doxorubicin-induced apoptosis to senescence. Oncogene (2003) 1.19
Coactivator PRIP, the peroxisome proliferator-activated receptor-interacting protein, is a modulator of placental, cardiac, hepatic, and embryonic development. J Biol Chem (2002) 1.15
Senescence-initiated reversal of drug resistance: specific role of cathepsin L. Cancer Res (2004) 0.95
Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism. Am J Physiol Cell Physiol (2008) 0.94
Role of the proteolytic hierarchy between cathepsin L, cathepsin D and caspase-3 in regulation of cellular susceptibility to apoptosis and autophagy. Biochim Biophys Acta (2008) 0.92
Invasive aspergillosis causing small bowel infarction in a patient of carcinoma breast undergoing chemotherapy. J Carcinog (2006) 0.86
Doxorubicin resistant neuroblastoma cells secrete factors that activate AKT and attenuate cytotoxicity in drug-sensitive cells. Cancer Lett (2002) 0.81
Differential expression of DNA-methyltransferases in drug resistant murine neuroblastoma cells. Cancer Detect Prev (2002) 0.81
MDR1 hypermethylation contributes to the progression of neuroblastoma. Mol Cell Biochem (2007) 0.80
Cellular conditioning with trichostatin A enhances the anti-stress response through up-regulation of HDAC4 and down-regulation of the IGF/Akt pathway. Aging Cell (2008) 0.80
Nerve growth factor regulates neuroectodermal tumor cell responses to mitogenic growth factors. J Neurosci Res (2003) 0.79
Anti-cancer effect of HIV-1 viral protein R on doxorubicin resistant neuroblastoma. PLoS One (2010) 0.76